Polymorphisms of the uridine-diphosphoglucuronosyltransferase 1A1 gene and coronary artery disease

Cellular and Molecular Biology Letters

Volumn 13, Issue 1, 2008, Pages 1-10

  Hsieh, Chia Jung ^a   Chen, Meng Jung ^b   Liao, Yung Liang ^b   Liao, Tung Nan ^a  

^a CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Antioxidant; Atherosclerosis; Bilirubin; Coronary artery disease; UGT1A1

Indexed keywords

BILIRUBIN; GLUCURONOSYLTRANSFERASE 1A1;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENE; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GLUCURONOSYLTRANSFERASE 1A1 GENE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION;

EID: 43549117283     PISSN: 14258153     EISSN: 16891392     Source Type: Journal    
DOI: 10.2478/s11658-007-0030-1     Document Type: Article

References (33)

1. Dudnik, L.B. and Khrapova, N.G. Characterization of bilirubin inhibitory properties in free radical oxidation reactions. Membr. Cell Biol.12 (1998) 233–240.
2. Neuzil, J. and Stocker, R. Free and albumin-bound bilirubin are efficient coantioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J. Biol. Chem.269 (1994) 16712–16719.
3. Nakagami, T., Toyomura, K., Kinoshita, T. and Morisawa, S. A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochim. Biophys. Acta1158 (1993) 189–193.
4. Mayer, M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin. Chem.4611 (2000) 1723–1727.
5. Schwertner, H.A., Jackson, W.G. and Tolan, G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin. Chem.40 (1994) 18–23.
6. Wu, T.W. Is serum bilirubin a risk factor for coronary artery disease? Clin. Chem.40 (1994) 9–10.
7. Schwertner, H.A and Joseph, R.F. Jr. Comparison of various lipid, lipoprotein, and bilirubin combinations as risk factors for predicting coronary artery disease. Atherosclerosis150 (2000) 381–387.
8. Hunt, S.C., Kronenberg, F., Eckfeldt, J.H., Hopkins, P.N., Myers, R.H. and Heiss G. Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study. Atherosclerosis154 (2001) 747–754.
9. Hopkins, P.N., Wu, L.L., Hunt, S.C., James, B.C., Vincent, G.M. and Williams, R.R. Higher serum bilirubin associated with decreased risk for early familial coronary artery disease. Arterioscler. Thromb. Vasc. Biol.16 (1996) 250–255.
10. Breimer, L.H., Wannamethee, G., Ebrahim, S. and Shaper, A.G. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin. Chem.41 (1995) 1504–1508.
11. Endler, G., Hamwi, A., Sunder-Plassmann, R., Exner, M., Vukovich, T., Mannhaleter, C., Wojta, J., Huber, K. and Wagner, O. Is low serum bilirubin an independent risk factor for coronary artery disease in men but not in women? Clin. Chem.49 (2003) 1201–1204.
12. Bosma, P.J. Inherited disorders of bilirubin metabolism. J. Hepatol.38 (2003) 107–117.
13. Ritter, J.K., Crawfoed, J.M. and Owens, I.S. Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells. J. Biol. Chem.266 (1991) 1043–1047.
14. Bosma, P.J., Seppen, J., Goldhoorn, B., Bakker, C., Oude Elferink RPJ., Chowdhury, J.R., Chowdhury, N.R. and Jansen, P.L. Bilirubin UDPglucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J. Biol. Chem.269 (1994) 17960–17964.
15. Huang, C.S., Luo, G.A., Huang, M.J, Yu, S.C. and Yang, S.S. Variations of the bilirubin uridine-diphosphoglucuronosyl transferase 1 A1 gene in healthy Taiwanese. Pharmacogenetics10 (2000) 539–544.
16. Raijalers, M.T.M., Jamsem, P.L.M., Steegers, E.A.P. and Peters, W.H.M. Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene. J. Hepatol.33 (2000) 348–351.
17. Ando, Y., Chida, M., Nakayama, K., Saka, H. and Kamataki, T. The UGT1A1*28 allele is relatively rare in a Japanese population. Pharmacogenetics8 (1998) 357–360.
18. Beutler, E., Gelbart, T. and Demina, A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: A balanced polymorphism for regulation of bilirubin metabolism? Proc. Natl. Acad. Sci. USA. 95 (1998) 8170–8174.
19. Maruo, Y., Poon, K.K.H., Oto, M., Iwai, M., Takahashi, H., Mori, A., Sato, H. and Takeuchi, Y. Co-occurrence of three different mutations in the bilirubin UDP-glucuronosyltransferase gene in a Chinese family with Crigler-Najjar syndrome type I and Gilbert’s syndrome. Clin. Genet.64 (2003) 420–423.
20. Maruo, Y., Nishizawa, K., Sato, H., Sawa, H. and Shimada, M. Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate-glucuronosyltransferase gene. Pediatrics106 (2000) 59–62.
21. Kadakol, A., Ghosh, S.S., Sappal, B.S., Sharma, G., Chowdhury, J.R. and Chowdhury, N.R. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Human Mutation16 (2000) 297–306.
22. Miners, J.O., McKinnon, R.A. and Mackenzie, P.I. Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance. Toxicology181–182 (2002) 453–456.
23. Ciotti, M., Chen, F., Rubaltelli, F.F. and Owens, I.S. Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease. Biochim. Biophys. Acta1407 (1998) 40–50.
24. Galbraith, R. Heme oxygenase: who needs it? Exp. Biol. Med.222 (1999) 299–305.
25. Tenhunen, R., Marver, H.S. and Shcmid, R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. P.N.A.S.61 (1968) 748–755.
26. Maines, M.D. The heme osygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol.37 (1997) 517–554.
27. Watanabe, Y., Nakajima, M., Ohashi, N., Kume, T. and Yokoi, T. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1. Drug Metab. Dispos.31 (2003) 589–595.
28. Shimizu, M., Tsuyuki, A., Yamamoto, C., Ohta, K., Matsushita, R., Suzuki, K., Matsumoto, Y. and Masamichi, F. Effects of Aspirin and/or salicylate on hydrolysis and glucuronidation of indomethacin in rat erythrocytes and hepatocytes. Biol. Pharm. Bull.26 (2003) 675–682.
29. Pruesaritanont, T., Subramanian, R., Xiaojun, Fang, Ma, B., Qiu, Y., Lin, J.H., Pearson, P.G. and Baillie, T.A. Glucuronidation of statins in animals and humans: A novel mechanism of statin lactonization. Drug Metab. Dispos.30 (2002) 505–512.
30. Wierzbicki, A.S. and Crook, M.A. Cholestatic liver dysfunction. Lancet354 (1999) 954.
31. Buchwald, H., Williams, S.E., Matts, J.P. and Boen, J.R. Lipid modulation and liver function tests. A report of the Program on the surgical control of hyperlipidemia (POSCH). J. Cardiovasc. Risk.9 (2002) 83–87.
32. Grosser, N., Abate, A., Oberle, S., Verman, H.J., Dennery, P.A., Becker, J.C., Pohle, T., Seidman, D.S. and Schroder, H. Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochim. Biophys. Res. Commun.308 (2003) 956–960.
33. Grosser, N., Hemmerle, A., Berndt, G., Erdamm, L., Jomlelmann, U., Schurger, S., Wijayanti, N., Immenschuh, S. and Shroder, H. The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Rad. Biol. Med.37 (2004) 2064–2071.